Pharmaceutical Stocks Worth Watching – February 26th

Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc., JD.com, and AstraZeneca are the five Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical stocks are shares of companies that develop, manufacture, and market drugs and other healthcare products. These stocks are influenced by factors such as new drug approvals, clinical trial results, and healthcare regulations, and they offer investors exposure to advancements in the medical and healthcare industries. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Shares of NYSE:LLY traded up $4.81 during trading on Wednesday, reaching $906.61. The stock had a trading volume of 1,939,150 shares, compared to its average volume of 3,728,997. Eli Lilly and Company has a 52 week low of $711.40 and a 52 week high of $972.53. The stock has a market capitalization of $859.62 billion, a PE ratio of 77.43, a P/E/G ratio of 1.40 and a beta of 0.42. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.15 and a quick ratio of 0.97. The business’s 50-day moving average price is $805.87 and its 200 day moving average price is $847.99.

Johnson & Johnson (JNJ)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

Shares of JNJ stock traded down $2.47 on Wednesday, reaching $163.62. The stock had a trading volume of 5,239,719 shares, compared to its average volume of 9,079,996. The firm has a market capitalization of $393.93 billion, a price-to-earnings ratio of 24.59, a P/E/G ratio of 2.56 and a beta of 0.52. The company has a quick ratio of 0.86, a current ratio of 1.11 and a debt-to-equity ratio of 0.43. Johnson & Johnson has a 12 month low of $140.68 and a 12 month high of $168.85. The firm’s 50-day moving average is $149.72 and its two-hundred day moving average is $155.92.

Merck & Co., Inc. (MRK)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.

Shares of MRK stock traded down $2.26 during trading hours on Wednesday, hitting $89.17. 7,392,887 shares of the company’s stock traded hands, compared to its average volume of 15,235,331. Merck & Co., Inc. has a 12 month low of $81.04 and a 12 month high of $134.63. The stock’s 50 day simple moving average is $95.11 and its 200 day simple moving average is $103.78. The stock has a market cap of $225.58 billion, a PE ratio of 13.22, a price-to-earnings-growth ratio of 0.77 and a beta of 0.38. The company has a quick ratio of 1.15, a current ratio of 1.36 and a debt-to-equity ratio of 0.79.

JD.com (JD)

JD.com, Inc. operates as a supply chain-based technology and service provider in the People's Republic of China. The company offers computers, communication, and consumer electronics products, as well as home appliances; and general merchandise products comprising food, beverage and fresh produce, baby and maternity products, furniture and household goods, cosmetics and other personal care items, pharmaceutical and healthcare products, industrial products, books, automobile accessories, apparel and footwear, bags, and jewelry.

JD traded up $2.33 during midday trading on Wednesday, reaching $42.40. The company had a trading volume of 12,115,855 shares, compared to its average volume of 12,318,092. The business has a 50-day moving average price of $37.99 and a two-hundred day moving average price of $36.01. The company has a debt-to-equity ratio of 0.18, a quick ratio of 0.90 and a current ratio of 1.17. The stock has a market cap of $66.86 billion, a PE ratio of 13.42, a P/E/G ratio of 0.31 and a beta of 0.40. JD.com has a 12-month low of $21.18 and a 12-month high of $47.82.

AstraZeneca (AZN)

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company’s marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.

Shares of NASDAQ AZN traded down $0.17 during midday trading on Wednesday, hitting $75.23. 5,978,219 shares of the company traded hands, compared to its average volume of 5,335,956. The stock has a 50-day moving average price of $69.09 and a 200 day moving average price of $73.08. The firm has a market cap of $233.31 billion, a P/E ratio of 33.27, a P/E/G ratio of 1.42 and a beta of 0.46. AstraZeneca has a 12-month low of $62.75 and a 12-month high of $87.68. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.74 and a current ratio of 0.93.